CClinicalTrials.gg
Sign In
Status unknownNCT02726815Updated Apr 4, 2016

Developing a Symptom List for Children With Cancer

An observational study in Paediatric Oncology Palliative Care, sponsored by Royal Marsden NHS Foundation Trust. Status unknown at 1 site in United Kingdom. Open to participants aged 7 Years to 18 Years. Per ClinicalTrials.gov, last updated 2016-04-04.

Sponsored by Royal Marsden NHS Foundation Trust · Observational

The sponsor has not verified this record recently (last verified Mar 2016), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
7 Years to 18 Years
Sex
All
01

Study summary

Primary Objective

The aim of this research study is to develop a comprehensive inventory of symptoms that occur in children with advanced cancer who are receiving a specialist palliative care service.

Secondary Objectives

  • To assess correlation between parent, child and nurse scores on the Memorial Symptom Assessment Scale (MSAS).
  • To identify symptom prevalence in children with advanced cancer as identified by the child/young person (CYP), nurse and parent (to be analysed separately for parent, child and nurse).
  • To identify whether there are any symptoms missing from the age appropriate MSAS as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse).
  • To identify whether any items on the age appropriate MSAS are not relevant to the population being studied (to be analysed separately for parent, child and nurse).
  • To identify which symptoms cause the most distress as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse).
  • To identify degree of severity of each symptom as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse).
  • To identify which symptoms occur most frequently as identified by the CYP, nurse and parent (to be analysed separately for parent, child and nurse).
  • To assess the trends between phase of illness and symptom profile, severity and distress.
02

Conditions studied

  • Paediatric Oncology Palliative Care

Browse trials for

03

In context

Neoplasms

9,371 studies on the registry are indexed under Neoplasms; 2,492 are open to participants now.

This study's planned enrollment of 40 is below the median of 205 across 1,684 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Royal Marsden NHS Foundation Trust is the lead sponsor of 262 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Any child/young person (CYP) aged 7 to 17 years and 364 days referred and accepted to the paediatric symptom care teams at the Royal Marsden will be eligible for inclusion.

Inclusion criteria

  • Any child/young person (CYP) aged 7 to 17 years and 364 days referred and accepted to the palliative care service (PATCH team) at the Royal Marsden (RM) will be eligible for inclusion. The PATCH team is responsible for co-ordinating palliative care services for children with both malignant and non-malignant conditions in the South Thames and South East Coast areas. The team can provide home visits, local hospital and hospice visits for symptom and palliative care advice. The team are also available by telephone 24 hours a day, 365 days a year to provide symptom advice to families and health care professionals from all settings who are caring for children known to the team. Acceptance to this service is via multidisciplinary team (MDT) discussion.

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment in the parent/carer
  • Lack of fluent English
  • Lack of ability to read and write English
  • Psychological concerns about the CYP and/or parent/carer. All potential participants will be discussed with the psychosocial team before being invited to participate.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Interventions

  • OtherQuestionnaire

    Questionnaire based study using a symptom assessment tool

06

What researchers measure

Primary outcomes

  1. Prevalence of all symptoms identified by child using the age appropriate Memorial Symptom Assessment Scale.

    Time frame: 18 months

  2. Prevalence of all symptoms identified by the parent using the same assessment tool as the child

    Time frame: 18 months

  3. Prevalence of all symptoms identified by the nurse

    Time frame: 18 months

07

Study locations

1 of 1 sites recruiting
  • Royal Marsden NHS Foundation Trust
    Sutton, Surrey SM2 5PT, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Plan to share internally at meetings as well as at conferences. Also plan to submit for publication in a peer reviewed journal.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02726815
Lead sponsor
Royal Marsden NHS Foundation Trust
Responsible party
Sponsor
First posted
Apr 4, 2016
Start date
Mar 2016
Primary completion
Sep 2017 (estimated)
Completion
Sep 2017 (estimated)
Last update
Apr 4, 2016

Study contacts

Lucy H Coombes, MSc
Contact
lucycoombes@nhs.net
0208 642 6011 ext. 3625
Anna-Karenia Anderson, MbchB
principal investigator · Royal Marsden NHS Foundation Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Neoplasms→

Other studies from this sponsor

Royal Marsden NHS Foundation Trust

Start the discussion